So, Gilteritinib is a kind of FLT3 inhibitor, and it’s mainly used for folks with AML who have FLT3 mutations after or haven’t responded to treatment. It stops the FLT3 kinase, which in turn reduces leukemia cells from multiplying. They give you these tablets – they’re the 40 mg coated kind.
You take them once a day and you’re supposed to take 120 mg all together. It comes in bottles, and each bottle’s got 90 tabs in it.
Reviews
There are no reviews yet.